These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 411758)

  • 21. Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus.
    Warren R; Rogolsky M; Wiley BB; Glasgow LA
    J Bacteriol; 1975 Apr; 122(1):99-105. PubMed ID: 123526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer of the plasmid for exfoliative toxin B synthesis in mixed cultures on nitrocellulose membranes.
    Rogolsky M; Beall BW; Wiley BB
    Infect Immun; 1986 Oct; 54(1):265-8. PubMed ID: 3093386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-mediated transformation in mutants of phage group 2 Staphylococcus aureus.
    Martin SM; Rogolsky M
    Can J Microbiol; 1980 Aug; 26(8):938-51. PubMed ID: 6450630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41.
    Koning S; van Belkum A; Snijders S; van Leeuwen W; Verbrugh H; Nouwen J; Op 't Veld M; van Suijlekom-Smit LW; van der Wouden JC; Verduin C
    J Clin Microbiol; 2003 Jul; 41(7):3017-21. PubMed ID: 12843036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a new toxin from a strain of Staphylococcus aureus isolated from a patient with nonmenstrual toxic shock syndrome.
    Hall WW; Blander S; Kakani R; Fischetti VA; Zabriskie JB
    Rev Infect Dis; 1989; 11 Suppl 1():S130-5; discussion S135-6. PubMed ID: 2928628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage conversion of exfoliative toxin A production in Staphylococcus aureus.
    Yamaguchi T; Hayashi T; Takami H; Nakasone K; Ohnishi M; Nakayama K; Yamada S; Komatsuzawa H; Sugai M
    Mol Microbiol; 2000 Nov; 38(4):694-705. PubMed ID: 11115106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.
    Arbuthnott JP; Billcliffe B
    J Med Microbiol; 1976 May; 9(2):191-201. PubMed ID: 819654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel positive regulatory element for exfoliative toxin A gene expression in Staphylococcus aureus.
    Sakurai S; Suzuki H; Hata T; Yoshizawa Y; Nakayama R; Machida K; Masuda S; Tsukiyama T
    Microbiology (Reading); 2004 Apr; 150(Pt 4):945-952. PubMed ID: 15073304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for plasmid-mediated toxin production in Bacillus anthracis.
    Mikesell P; Ivins BE; Ristroph JD; Dreier TM
    Infect Immun; 1983 Jan; 39(1):371-6. PubMed ID: 6401695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C55 bacteriocin produced by ETB-plasmid positive Staphylococcus aureus strains is a key factor for competition with S. aureus strains.
    Kawada-Matsuo M; Shammi F; Oogai Y; Nakamura N; Sugai M; Komatsuzawa H
    Microbiol Immunol; 2016 Mar; 60(3):139-47. PubMed ID: 26801833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of protease from a mixture of exfoliative toxin and newborn-mouse epidermis.
    Ninomiya J; Ito Y; Takiuchi I
    Infect Immun; 2000 Sep; 68(9):5044-9. PubMed ID: 10948123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1991 Oct; 14(4):357-62. PubMed ID: 1775093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous alpha-toxin mutants of Staphylococcus aureus.
    Dalen AB
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):333-8. PubMed ID: 136860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Demonstration by electrosyneresis of 2 exfoliation serotypes produced by Staphylococcus aureus].
    Piémont Y; Monteil H
    Ann Microbiol (Paris); 1983; 134A(2):169-75. PubMed ID: 6870085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1974 Oct; 10(4):851-61. PubMed ID: 4139120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple procedure for the purification of staphylococcal alpha-toxin.
    Dalen AB
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):326-32. PubMed ID: 11636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesteryl de-esterifying enzyme from Staphylococcus aureus: separation from alpha toxin, purification, and some properties.
    Harvie NR
    Infect Immun; 1977 Mar; 15(3):863-70. PubMed ID: 858644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning and expression of the epidermolytic toxin A gene of Staphylococcus aureus.
    O'Toole PW; Foster TJ
    Microb Pathog; 1986 Dec; 1(6):583-94. PubMed ID: 3508500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of staphylococcal exfoliative toxin by slide latex agglutination.
    Murono K; Fujita K; Yoshioka H
    J Clin Microbiol; 1988 Feb; 26(2):271-4. PubMed ID: 3343322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene.
    Navaratna MA; Sahl HG; Tagg JR
    Infect Immun; 1999 Aug; 67(8):4268-71. PubMed ID: 10417203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.